Research record
Overview
Compound name: Ipamorelin
Alternative names: N/A (commonly referenced as Ipamorelin)
Compound classification: Growth hormone–releasing peptide (GHRP)
Brief factual description:
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. It is designed to stimulate endogenous growth hormone release through selective activation of ghrelin (GHS-R1a) receptors.
Mechanism of Action
Primary biological targets: Growth hormone secretagogue receptor (GHS-R1a)
Affected systems: Endocrine (growth hormone axis)
Receptor selectivity: High selectivity for GH release compared to earlier GHRPs
Downstream signaling effects:
Pulsatile growth hormone secretion via hypothalamic–pituitary axis activation without significant appetite stimulation.




